Sulfonohydrazide as a potential inhibitor of SARS-CoV-2 infection
Abstract The COVID-19 pandemic caused immense mortality and morbidity reporting 704,753,890 cases worldwide. The repercussions of this pandemic are still being felt in the form of newly evolving variants and infections. The pandemic has pointed towards the need for the development of new and effecti...
Saved in:
| Main Authors: | Zoha Khan, Saba Farooq, Atia-tul-Wahab, Hana’a Iqbal, Farzana Naz, Thomas Iftner, Khalid M. Khan, Muhammad Yusuf, M. Iqbal Choudhary |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-03685-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Multi-Model Machine Learning Framework for Identifying Raloxifene as a Novel RNA Polymerase Inhibitor from FDA-Approved Drugs
by: Nhung Thi Hong Van, et al.
Published: (2025-04-01) -
RNA interference of Aspergillus flavus in response to Aspergillus flavus partitivirus 1 infection
by: Yinhui Jiang, et al.
Published: (2023-11-01) -
Corrigendum: RNA interference of Aspergillus flavus in response to Aspergillus flavus partitivirus 1 infection
by: Yinhui Jiang, et al.
Published: (2025-01-01) -
Anti-SARS-CoV-2 prodrug ATV006 has broad-spectrum antiviral activity against human and animal coronaviruses
by: Tiefeng Xu, et al.
Published: (2025-05-01) -
A5—A dual-target antiviral compound that rewrites the rules of influenza therapy
by: Shibo Jiang
Published: (2025-08-01)